Outset Medical (NASDAQ:OM) reported quarterly losses of $(0.80) per share which missed the analyst consensus estimate of $(0.72) by 11.11 percent. This is a 4.76 percent increase over losses of $(0.84) per share from the same period last year. The company reported quarterly sales of $31.635 million which beat the analyst consensus estimate of $29.833 million by 6.04 percent. This is a 0.75 percent increase over sales of $31.400 million the same period last year.